In these guidelines, the American Heart Association provides updated guidance for resuscitation of adults and children in cardiac arrest or with a life-threatening condition due to special ...

The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), maker Milestone Pharmaceuticals announced. The rapid-acting L-type calcium ...

Calcium channel blockers were linked to a marginally slower rate of visual field deterioration in glaucoma patients, though not clinically significant. The study involved a retrospective longitudinal ...

Toxicity due to calcium-channel blockers (CCBs) or β-blockers results in significant morbidity and mortality. [9] The manifestations of toxicity are generally extensions of the drugs' pharmacologic ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the first polypill designed for initial treatment of hypertension. Approval was based on the ...

Treatment for coronary artery disease (CAD) involves lifestyle changes alongside medications such as antiplatelets and statins. There are many different medications to treat CAD. Treatment for CAD is ...

A small Chinese trial compared the effects of three oral antispastic medications for 24 weeks post-coronary artery bypass grafting (CABG) in relation to spasm-induced radial artery graft failure.

Sodium channel blockers are medications that help reduce abnormal electrical activity in the heart. They can also lower the risk of severe complications such as stroke or sudden cardiac death. Sodium ...

Potassium channel blockers are a type of medication used to treat conditions like cardiac arrhythmias. They block the movement of potassium channels in the body, disrupting the body’s electrical ...

Table 2. The IC 50 values and inhibitory effects of nisoldipine and nimodipine on ivacaftor metabolism in RLM and HLM. In the published article, there was an error ...